Elevated IL-6 and TNF-α levels have also been consistently observed in individuals at clinical high risk for psychosis (CHR-P) [27] and in first-episode psychosis (FEP) patients [28], suggesting their involvement in illness onset and progression. This evidence concerns the gene IL6 and psychotic disorder.